Adaptive COVID-19 Treatment Trial (ACTT)
Research Grant
Administered By
Duke Human Vaccine Institute
Awarded By
Leidos Biomedical Research, Inc.
Start Date
March 18, 2020
End Date
August 30, 2021
Administered By
Duke Human Vaccine Institute
Awarded By
Leidos Biomedical Research, Inc.
Start Date
March 18, 2020
End Date
August 30, 2021